Q3: 2025-11-06 Earnings Summary
EPS of -$0.19 misses by $0.03
| Revenue of $8.96M (37.62% Y/Y) beats by $2.62M
AbCellera Biologics Inc. (ABCL) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST
Company Participants
Tryn Stimart – Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer
Carl L. Hansen – CEO, President & Chairperson
Andrew Booth – Chief Financial Officer
Conference Call Participants
Malcolm Hoffman – BMO Capital Markets Equity Research
Andrea Tan – Goldman Sachs Group, Inc., Research Division
Joshua Nickerson – Stifel, Nicolaus & Company, Incorporated, Research Division
Faisal Khurshid – Leerink Partners LLC, Research Division
Steven Dechert – KeyBanc Capital Markets Inc., Research Division
Jacqueline Kisa – TD Cowen, Research Division
Presentation
Operator
Good afternoon, and welcome to AbCellera’s Third Quarter 2025 Business Update Conference Call. My name is Cameron, and I’ll facilitate the audio portion of today’s interactive broadcast. [Operator Instructions] At this time, I would like to turn the call over to Tryn Stimart, AbCellera’s Chief Legal and Compliance Officer. You may proceed.
Tryn Stimart
Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer
Thank you. Hello, everyone. Thank you for joining us for AbCellera’s Third Quarter 2025 Earnings Call. I’m Tryn Stimart, AbCellera’s Chief Legal and Compliance Officer. Dr. Carl Hansen, AbCellera’s President and CEO; and Andrew Booth, AbCellera’s Chief Financial Officer, are also on today’s call. During this call, we anticipate making projections and forward-looking statements based on our current expectations and in accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Our actual results could differ materially due to several factors outlined in our latest Form 10-K and subsequent Forms 10-Q and 8-Q (sic) [ 8-K ] filed with the Securities and Exchange Commission.
AbCellera is not obligated to update any forward-looking statements, whether due to new information, future events or otherwise. Our presentation today, our earnings press release and our SEC filings are available on our Investor Relations
